We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Targeting the Vaginal Microbiome for Urogenital and Reproductive Health
Industry Insight

Technology Networks , recently spoke with Dr. Jacques Ravel (Chief Scientist of LUCA Biologics) and Luba Greenwood (CEO of LUCA Biologics) to learn more about what the vaginal microbiome is, how it can contribute to human pathology and the development of novel therapeutics in this space that are approaching clinical trials.

Read More

Harnessing the Immune System for Early Cancer Detection
Industry Insight

With the number of new cancer cases worldwide per year predicted to rise to 23.6 million by 2030, it seems as pertinent as ever that the disease is stopped early in its tracks. We spoke with Mike Fisher, Ph.D., Commercial Director of Oncimmune, to find out more about a trial utilizing a simple blood test for early detection of lung cancer.

Read More

Exploiting Immunobiology To Treat Severe Autoimmune and Inflammatory Disorders
Industry Insight

Technology Networks recently had the pleasure of speaking with Bruce Steel, CEO Equillium, Inc. to learn more about how they are leveraging their comprehensive understanding of immunobiology to develop novel treatments for inflammatory and autoimmune disorders.

Read More

Yeast, A "Rising" Approach to Manufacturing Collagen
Industry Insight

Technology Networks spoke with Jonathan Widdowson, Director of ProColl and Enterprise Fellow at the Royal Academy of Engineering Enterprise Hub, to learn more about how yeast can be used to manufacture collagens and the applications of this approach.

Read More

A New Generation of Recombinant Monoclonal Antibodies
Industry Insight

Technology Networks spoke with Isaku Tanida, Head of Protein and Pathway Technologies, Life Science at Merck to learn about Merck's ZooMAb® recombinant antibodies. These antibodies are developed from a B-cell immortalization technology which enables production in a variety of species.

Read More

Drugging the Microbiome To Treat Obesity
Industry Insight

Technology Networks recently spoke with Paul-Peter Tak, President & CEO, Kintai Therapeutics, to learn more about the anti-obesity agent the company is currently developing.

Read More

Efforts To Sequence the Coronavirus Continue As New Gene Sequencer Is Launched in Asia
Industry Insight

Technology Networks spoke with GenapSys to learn more about the sequencer which is "100x smaller and less expensive than legacy high-throughput sequencers" and how it can be applied to study the Coronavirus.

Read More

Data from Direct-to-Consumer Genetic Tests Used To Create a Drug for Inflammatory Diseases
Industry Insight

At the beginning of the year, direct-to-consumer (DTC) genetic testing company 23andMe announced that they have generated a bispecific antibody that blocks the IL-36 cytokine family associated with multiple inflammatory diseases. Technology Networks spoke with Christine Pai from 23andMe to find out more.

Read More

An Online Educational Resource for Cell Scientists
Industry Insight

Introduced back in March 2019, Cell MentorTM is an online educational resource for biology students and researchers, created by Cell Signaling Technology and Cell Press. To open the resource up to even more scientists, a Chinese version of the site was recently launched.

Read More

Feeding the Microbiome: How MMTs Could Change the Landscape of Therapeutics
Industry Insight

Technology Networks recently spoke with Johan van Hylckama Vlieg, Ph.D., Chief Scientific Officer at Kaleido Biosciences, to learn more about the development of Microbiome Metabolic Therapies (MMTs), and how Kaleido are advancing a pipeline of MMTs for a variety of disease indications.

Read More

 
Advertisement